(Q53515076)
Statements
Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma. (English)
D L Fairclough
B A Murphy
J Bacik
L H Schwartz
D M Nanus
T Mariani
P Loehrer
G Wilding
D Cella
M Mazumdar
1 August 2000
18
16
2972-2980